Pathology seminar to focus on potential therapy for common liver cancer

Devanand Sarkar, M.B.B.S., Ph.D., a professor of human and molecular genetics at Virginia Commonwealth University in Richmond, is the guest speaker for the USA Department of Pathology's upcoming Research Seminar Series.

He will present "RNAi for AEG-1: Potential Therapy for NASH and HCC" at noon on Thursday, April 21, in the Strada Patient Care Center conference room. Lunch will be served.

Sarkar also serves as the associate director of training and education at the VCU Massey Cancer Center. His research focuses on understanding the molecular mechanism of hepatocellular carcinoma (HCC), the most common type of primary liver cancer, and developing novel, targeted and effective therapeutic strategies.

For more information, contact Patrick Carlisle at 251-471-7753 or pcarlisle@health.southalabama.edu.